TylenolRecall

Johnson and Johnson's McNeil Consumer Healthcare recalled almost 800,000 bottles of Tylenol, Benadryl, Sudafed PE, and Sinutab products in two recalls linked to previous problems for the beleaguered over-the-counter drug manufacturer. McNeil spokeswoman Bonnie Jacobs told Consumer Ally about...

Pfizer Inc. subsidiary Greenstone LLC recalled one lot of its Citalopram depression medicine and its prostate drug Finasteride because the wrong labels may have been put on the bottles, said the U.S. Food and Drug Administration. Greenstone said in a recall notice that bottles of Citalopram, a...

Millions of packages of Tylenol, Benadryl, Sudafed and Sinutab products are being recalled by manufacturer Johnson & Johnson's McNeil Consumer Healthcare due to questions about machine cleanliness and when the over-the-counter medicines were made. A recall of certain lots of Rolaids...

Johnson & Johnson has announced yet another Tylenol recall, and once again, a foul odor is the culprit. McNeil Consumer Healthcare, a division of Johnson & Johnson, announced the recall on Monday of a single lot of Tylenol 8-Hour caplet, 50-count bottles it says were sold in the U. S. and...

Johnson & Johnson (JNJ) is recalling Tylenol products because of a musty odor, the company's third such recall in 12 months. J&J is yanking a line of Tylenol 8-hour caplets containing 127,728 bottles after customers complained of a musty smell from the pills, Bloomberg News said. The smell...

The world's top drug maker recalled 191,000 bottles of its anti-cholesterol drug Lipitor due to reports of a moldy odor emanating from bottles supplied by a third-party – the same problem that resulted in the recall of millions of Tylenol bottles. Pfizer spokesman Rick Chambers said the...

In testimony before Congress Thursday, Johnson & Johnson's CEO apologized for the problems that have beset his company, including the quality issues with its children's medicines and the "phantom recall" of a batch of Motrin. He also said new batches of its children's medicines should start shipping next week.

Members of a Congressional Committee today questioned whether some of the problems that resulted in several recalls of over-the-counter medicines at drug maker Johnson & Johnson were symptoms of a "too cozy" relationship between the company and the Food and Drug Administration. Meanwhile...

Recalls of Tylenol, Motrin and Benadryl might have received the most attention, but they were just part of the story as recalls of over-the-counter (OTC) and prescription drugs quadrupled in 2009, and are on track to hit alarming heights in 2010. The Food and Drug Administration (FDA) reported...

Johnson & Johnson's earnings for the second quarter of 2010 rose 5.4% to $3.4 billion, or $1.23 per share, from $3.2 billion or $1.15 per share, the company announced Tuesday morning. Adjusted earnings, which exclude litigation costs, were $1.21 per share.